NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Right! Thanks, Lykiri, the board member's replies are ... interesting.

If it was "delayed in assessment", it could be argued that the application might have "major objections". Since it is NOT delayed in assessment (nor, interestingly, "has not been" delayed), one can logically, IMO, assume the assessment is moving forward "normally".

This supports the positive view that the application is proceeding through the normal (albeit lengthy) assessment and inspection phases, and that it was never among the applications with major issues precluding approval.

To confirm this application has not been in backlog or delayed in assessment.

The "has not been" comment seems to indicate that at no time has the application been in backlog, either. Which is unusual, given the time the application has taken thus far.

Still... if it's not in backlog, then DCVax-L is certainly NOT one of the somewhat wounded "outstanding" applications within backlog with major objections.
And if it's not delayed by assessment, I would think it's not in another RFI clock-off.

So the question is, if it's not in backlog, and it's not delayed by assessement, and it's not been refused (or we'd have to be told by the company)... where is it?

:)